Finally, the immune‐related pathways were significantly regulated in most cancer patients with high expression of MIDN, including BLCA, COAD, ESCA, KICH, KIRP, LAML, LIHC, LUAD, LUSC, PAAD, PCPG, PRAD, STAD, THCA, and UCEC. Here, MIDN is linked to cancer.